|  | |
| Company | Merck & Co., Inc. | Merck & Co., Inc. |
| Item | Cosopt | Trusopt |
| Price | Inquire | Inquire |
| Description | COSOPT (dorzolamide hydrochloride-timolol maleate ophthalmic solution) is the combination of a
topical carbonic anhydrase inhibitor and a topical beta-adrenergic receptor blocking agent. | TRUSOPT (dorzolamide hydrochloride ophthalmic solution) is a carbonic anhydrase inhibitor
formulated for topical ophthalmic use. |
| Size | 5 mL, 10 mL | 5 mL, 10 mL |
| Indication | COSOPT is indicated for the reduction of elevated intraocular pressure in patients with open-angle
glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve
target IOP determined after multiple measurements over time). The IOP-lowering of COSOPT b.i.d. was
slightly less than that seen with the concomitant administration of 0.5% timolol b.i.d. and 2.0%
dorzolamide t.i.d. | TRUSOPT Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in
patients with ocular hypertension or open-angle glaucoma. |
| Storage | Store COSOPT at 15 - 30° C (59 - 86° F). Protect from light. | Store TRUSOPT Ophthalmic Solution at 15 - 30° C (59 - 86° F). Protect from light. |
| How Supplied | Solution | 2% Solution |
| Generic Name | Timolol Maleate / Dorzolamide | Dorzolamide |
| Get quote | Inquire | Inquire |